Growth suppression of non-small cell lung carcinoma cells by the introduction of the p16INK4A gene

International Journal of Oncology

Volumn 10, Issue 1, 1997, Pages 33-39

  Adachi, Jun Ichi ^a   Kohno, Takashi ^a   Baeg, Gyeong Hun ^b   Akiyama, Tetsu ^b   Yokota, Jun ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

G1 arrest; Non small cell lung cancer; p16 gene

Indexed keywords

CYCLIN DEPENDENT KINASE BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL;

EID: 0031034949     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.10.1.33     Document Type: Article

References (45)

1. Serrano M, Hannon GJ and Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704-707, 1994.
2. INK4A/ MTS1- and MTS2-related CDK6 inhibitor, correlates with wild-type pRB function. Gene Develop 8: 2939-2952, 1994.
3. Kato J, Matsushime H, Hiebert SW, Ewen ME and Sherr CJ: Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Gene Develop 7: 331-342, 1993.
4. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE and Skolnick MH: A cell cycle regulator potentially involved in the genesis of many tumor types. Science 264: 436-440, 1994.
5. Nobori T, Muira K, Wu DJ, Lois A, Takabayashi K and Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in human cancers. Nature 386: 753-756, 1994.
6. Cairns P, Mao L, Merlo A, Lee DJ, Schwab D, Eby Y, Tokino K, van der Riet P, Elaugrund JE and Sidransky D: Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265: 415-416, 1994.
7. INK4 in human cancer. Proc Natl Acad Sci USA 91: 11045-11049, 1994.
8. Jen J, Harper JW, Bigner SH, Bigner DD, Papadopoulos N, Markowitz S, Willson JKV, Kinzler KW and Vogelstein B: Deletions of p16 and p15 genes in brain tumors. Cancer Res 54: 6353-6358, 1994.
9. Cairns P, Polascik TJ, Eby Y, Tokino K, Califano J, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho KR, Hedrick L, Bova GS, Isaacs W, Schwab D and Sidransky D: Frequency of homozygous deletion at p16/CDKN2 in primary human tumors. Nature Genet 11: 210-212, 1995.
10. Caldas C, Hahn SA, Da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ and Kern SE: Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet 8: 27-32, 1394.
11. Walker DG, Duan W, Popvic EA, Kaye AH, Tomlinson FH and Lavin M: Homozygous deletions of the multiple tumor suppressor gene 1 in progression of human astrocytomas. Cancer Res 55: 20-23, 1995.
12. Zhou X, Tarmin L, Yin J, Jiang HY, Suzuki H, Rhyu MG, Abraham JM and Meltzer SJ: The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene 9: 3737-3741, 1994.
13. Mori T, Miura K, Aoki T, Nishihira T, Mori S and Nakamura Y: Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res 54: 3396-3397, 1994.
14. Hussussian CJ, Struewing JP, Goldstein AM, Higgins PA, Ally DS, Sheahan MD, Clark WJ, Tucker MA and Dracopoli NC: Germline p16 mutations in familial melanoma. Nature Genet 8: 15-21, 1994.
15. INK4 function. Nature Genet 10: 114-116, 1995.
16. Merlo A, Herman JG, Mao L, Lee DJ, Gabrielson E, Burger PC, Baylin SB and Sidransky D: 5' CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med 1: 686-692, 1995.
17. Herman JG, Merlo A, Mao L, Lapidus RG, Issa JPJ, Davidson NE, Sidransky D and Baylin SB: Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 55: 4525-4530, 1995.
18. Gonzalez-Zulueta M, Bender CM, Yang AS, Nguyen T, Beart RW, Van Tornout JM and Jones PA: Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res 55: 4531-4535, 1995.
19. INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res 55: 6200-6209, 1995.
20. INK4 requires functional retinoblastoma protein. Proc Natl Acad Sci USA 92: 6289-6293, 1995.
21. Arap W, Nishikawa R, Fumari FB, Cavenee WK and Huang HJS: Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res 55: 1351-1354, 1995.
22. INK4. Science 267: 249-252, 1995.
23. Koh J, Enders GH, Dynlacht BD and Harlow E: Tumor-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375: 506-510, 1995.
24. Lucas J, Parry D, Aagaard L, Mann DJ, Barkov J, Strauss M, Peter G and Bartek J: Retinoblastoma-protein-dependent cell cycle inhibition by the tumor suppressor p16. Nature 375: 503-506, 1995.
25. INK4 protein is restricted to the subset of lung cancer cell lines that retains the wild-type RB. Oncogene 9: 3375-3378, 1994.
26. INK4 expression in primary lung cancers and cell lines. Cancer Res 55: 505-509, 1995.
27. Washimi O, Nagatake M, Osada H, Ueda R, Koshikawa T, Seki T, Takahashi T and Takahashi T: In vivo occurrence of p16 (MTS1) and p15 (MTS2) alterations preferentially in non-small cell lung cancer. Cancer Res 55: 514-517, 1995.
28. Xiao S, Li D, Corson JM, Vijg J and Fletcher JA: Codeletion of p15 and p16 genes in primary non-small cell lung carcinoma. Cancer Res 55: 2968-2971, 1995.
29. Hayashi N, Sugimoto Y, Tsuchiya E, Ogawa M and Nakamura Y: Somatic mutations of the MTS (multiple tumor suppressor) 1/CDK4I (cyclin-dependent kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas. Biochem Biophys Res Commun 202: 1426-1430, 1994.
30. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res 55: 1448-1451, 1995.
31. Yokota J, Akiyama T, Fung YK, Benedict WF, Namba Y, Hanaoka M, Wada M, Terasaki T, Shimosato Y, Sugimura T and Terada M: Altered expression of the retinoblastoma (RB) gene in small-cell carcinoma of the lung. Oncogene 3: 471-475, 1988.
32. Horowitz JM, Park SH, Bogenmann E, Cheng JC, Yandell DW, Kaye FJ, Minna JD, Dryja TP and Weinberg RA: Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. Proc Natl Acad Sci USA 87: 2775-2779, 1990.
33. Hensel CH, Hsieh CL, Gazdar AF, Johnson BE, Sakaguchi AY, Naylor SL, Lee WH and Lee EYH: Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res 50: 3067-3072, 1990.
34. Li Y, Nichols MA, Shay JW and Xiong Y: Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54: 6078-6082, 1994.
35. INK4. Cancer Res 54: 5816-5820, 1994.
36. INK4/MTS1 tumour suppressor gene product. EMBO J 14: 503-511, 1995.
37. Shimizu E, Coxon A, Otterson GA, Steinberg SM, Kratzke RA, Kim YW, Fedorko J, Oie H, Johnson B, Mulshine JL, Minna JD, Gazdar AF and Kaye FJ: RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma. Oncogene 9: 2441-2448, 1994.
38. INK4A gene mediated by an adenovirus vector. Cancer Res 55: 3250-3253, 1995.
39. Adachi JI, Ookawa K, Shiseki M, Okazaki T, Tsuchida S, Morishita K and Yokota J: Induction of apoptosis but not G1 arrest by expression of the wild-type p53 gene in small-cell lung carcinoma. Cell Growth Differ 7: 879-886, 1996.
40. Imai Y, Matsushima Y, Sugimura T and Terada M: A simple and rapid method for generating a deletion by PCR. Nucleic Acids Res 19: 2785, 1991.
41. Kaye FJ, Kratzke RA, Gerster JL and Horowitz JM: A single amino acid substitution results in a retinoblastoma protein defective in phosphorylation and oncoprotein binding. Proc Natl Acad Sci USA 87: 6922-6926, 1990.
42. INK4 expression is frequent in high grade gliomas. Cancer Res 55: 1941-1945, 1995.
43. Maniatis T, Fritsch EF and Sambrook J: Molecular cloning: a laboratory manual. Cold Spring Harbor Lab., Cold Spring Harbor, NY, 1982.
44. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity. J Immunol Methods 65: 55-63, 1983.
45. Ookawa K, Shiseki M, Takahashi R, Yoshida Y, Terada M and Yokota J: Reconstitution of the RB gene suppress the growth of small-cell lung carcinoma cells carrying multiple genetic alterations. Oncogene 8: 2175-2181, 1993.